Blog

Rapid Pathogen Detection: What It Is, How It Works, and Why It Matters

Rapid Pathogen Detection: What It Is, How It Works, and Why It Matters

In today’s world, rapid pathogen detection is critical for preventing outbreaks, protecting crops, and managing global health challenges. While traditional culture-based methods are often too slow and lack sensitivity, advanced pathogen detection systems, especially PCR pathogen detection enable faster, more reliable identification of harmful organisms. These modern solutions are transforming how we respond to emerging threats and ensure safety in healthcare, agriculture, and beyond. 

At 3CR Bioscience, we’ve taken PCR-based detection to the next level with our patented PACE® and PACE OneStep RT-PCR technologies. Designed for flexibility and high throughput, our systems are used globally across sectors including agriculture, clinical research, and environmental monitoring. This article explores the benefits of PCR-based pathogen detection systems, with real-world case studies demonstrating the power and versatility of our approach. 

What is rapid pathogen detection? 

Rapid pathogen detection refers to modern testing methods that quickly identify harmful microorganisms, such as bacteria, viruses, and fungi in a sample. Traditional culture-based techniques can take days to deliver results because pathogens must grow before they can be detected. In contrast, rapid pathogen detection systems use advanced tools like PCR and other molecular assays to detect pathogens directly and much faster.

This speed and accuracy allow healthcare providers, researchers, food producers, and environmental laboratories to act quickly, helping prevent outbreaks, protect public health, and reduce safety risks.

Overview of Modern Pathogen Detection Systems

Modern pathogen detection systems are vital for fast and accurate identification of microorganisms in clinical, agricultural, food, and environmental samples. These rapid pathogen detection technologies improve response times, support public health, and strengthen food and biosafety worldwide.

Typical pathogen detection systems include:

  • PCR pathogen detection for sensitive identification of bacteria, viruses, and fungi
  • Rapid immunoassays for quick screening in point-of-care settings
  • Automated high-throughput platforms for large-scale laboratory testing
  • Pathogen detection consumables designed for consistent, reliable workflows

Key benefits of advanced pathogen testing:

  • Fast results to prevent outbreaks and guide immediate actions
  • High sensitivity and specificity to ensure diagnostic accuracy
  • Scalable performance for routine or emergency testing demands
  • Versatile application across healthcare, food safety, and environmental monitoring

As demand for rapid and scalable microbiological diagnostics grows, modern systems are transforming global pathogen surveillance and enabling smarter decisions across multiple industries.

PCR Pathogen Detection

PCR pathogen detection is one of the most reliable and widely used methods for identifying harmful microorganisms at the genetic level. By amplifying specific DNA or RNA targets, PCR enables rapid pathogen detection even when only trace amounts of bacteria, viruses, or fungi are present in a sample. This high sensitivity and specificity make PCR the gold standard for pathogen testing in clinical research, agricultural biosecurity, food safety, and environmental monitoring.

Modern PCR-based pathogen detection systems offer:

  • Fast turnaround times for timely decision-making
  • Accurate detection of both known and emerging pathogens
  • Compatibility with high-throughput workflows
  • Support for real-time surveillance and outbreak prevention

With advancements such as multiplex assays and automated workflows, PCR pathogen detection continues to evolve, providing faster, scalable solutions that strengthen research for global health and biosafety.

What are pathogen detection consumables? 

Pathogen detection consumables are specialized products such as reagents, tubes, PCR plates, pipette tips, and extraction kits used in laboratory testing for the identification of harmful microorganisms. These consumables are designed to ensure the accuracy, reliability, and efficiency of rapid pathogen detection systems by supporting sample preparation, amplification, and analysis processes.

PACE and PACE OneStep RT-PCR: Sensitivity and Precision in High-Throughput PCR Pathogen Detection

At the core of 3CR’s technology is PACE (PCR Allele Competitive Extension)—a patented, high-performance fluorescent PCR genotyping chemistry. PACE enables accurate detection of DNA variants, including single nucleotide polymorphisms (SNPs), across diverse organisms.

Our enhanced PACE OneStep RT-PCR integrates reverse transcription and PCR into a single reaction, allowing for the detection of both DNA- and RNA-based pathogens. This innovation supports rapid pathogen detection workflows that are high-throughput, cost-effective, and easy to adopt.

How PACE Works in Pathogen Detection

PACE assays are tailored to target unique genetic sequences found in pathogen genomes, enabling specific and reliable detection. They can be designed to:

  • Identify the presence or absence of a pathogen in a sample.
  • Distinguish between strains or variants of the same pathogen.
  • Track the evolution of pathogens over time or across populations.

Advantages of Using PACE-Based Systems

Speed: Results in hours, not days.

High Throughput: Ideal for screening hundreds or thousands of samples.

Cost Efficiency: Uses universal reagents with minimal primer requirements.

Flexibility: Detects pathogens in plants, animals, humans, or environmental samples.

Scalability: Easily adapted to different lab workflows or sample volumes.

Case Study: SARS-CoV-2 Variant Detection in Human Populations

During the COVID-19 pandemic, genetic surveillance of viral variants became a global priority. Traditional whole-genome sequencing, though powerful, was expensive and logistically challenging for widespread use.

In response, 3CR Bioscience partnered with the University of Bristol to develop a PACE OneStep RT-PCR pipeline for rapid pathogen detection and variant tracking of SARS-CoV-2. Instead of sequencing entire genomes, the method genotyped SNPs directly from RNA samples to differentiate circulating viral strains.

A workflow showing how SARS-CoV-2 PCR genotyping can be used to identify circulating SARS-CoV-2 variants for pathogen detection and monitoring.

High-Resolution Tracking with Minimal Resources

Using a panel of just 19 SNP markers, the team could distinguish 59 different SARS-CoV-2 genotypes. This rapid, low-cost method provided critical insights into transmission patterns and the emergence of variants, without overburdening testing infrastructure.

The publicly available SNP genotyping pipeline has since been adopted by public health labs for real-time variant monitoring and remains adaptable as new variants arise.

Case Study: Pathogen Detection in Cotton Crops

In agriculture, early pathogen detection is vital to preventing the spread of crop diseases. One such threat is Cotton leafroll dwarf virus (CLRDV)—a single-stranded RNA virus that can cause devastating yield losses.

From Two-Step to One-Step Detection

Researchers at Texas A&M University collaborated with 3CR Bioscience to streamline detection of CLRDV. Building on the lab’s existing use of PACE genotyping, they developed a PACE OneStep RT-PCR assay that combined reverse transcription and DNA amplification into a single step.

The assay accurately differentiated infected and healthy plants and was validated against known sample sets. Its low cost, speed, and simplicity make it ideal for widescale crop monitoring.

A workflow and data plot showing how PACE PCR genotyping can be used for pathogen detection, to detect Cotton Leafroll Dwarf Virus in Cotton crops.

Customisable for Other Crop Threats

Thanks to its modular design, PACE and PACE OneStep RT-PCR can be adapted to target other plant pathogens by altering the primer sequences. This makes it a valuable platform for responding to emerging threats in global agriculture.

Pathogen Detection and Beyond

Beyond direct pathogen detection, PACE technology supports broader research in genomics and epidemiology. Its ability to detect SNPs and small insertions/deletions (Indels) enables investigations into:

  • Genetic predispositions to human diseases such as cancer and cardiovascular conditions.
  • Outbreak investigations involving bacterial, viral, or fungal pathogens.
  • Environmental pathogen monitoring in water or soil samples.
  • PACE offers a reliable tool for both clinical research and public health surveillance.

Pathogen Testing for Safety and Disease Prevention

Pathogen testing is essential for identifying harmful microorganisms that pose risks to human health, food production, and the environment. By analyzing clinical, agricultural, or industrial samples, pathogen testing ensures early detection of bacteria, viruses, fungi, and other contaminants before they can spread or cause damage. This proactive approach helps prevent disease outbreaks, maintain product quality, and comply with regulatory safety standards.

Pathogen testing is widely used in:

  • Healthcare research to guide treatment and protect patients
  • Food and beverage safety to prevent contamination and spoilage
  • Agriculture and livestock management to detect crop and animal pathogens early
  • Environmental monitoring to track water, soil, and air quality

As the need for rapid pathogen detection grows worldwide, advanced molecular methods, including PCR-based diagnostics are replacing slower culture-based testing, enabling faster action and significantly improving biosurveillance and public safety outcomes.

An Open Invitation for Collaboration and Feedback

At 3CR Bioscience, we’re proud to support researchers and organisations working on the front lines of health, agriculture, and environmental safety. We’re continually refining our pathogen detection systems and welcome feedback from our users on how we can improve our solutions or support emerging needs.

We invite you to explore how PACE or PACE OneStep RT-PCR can be adapted for your application. From customised assay development to high-throughput implementation, our team is here to help.

Conclusion

The need for rapid pathogen detection continues to grow across industries. Whether monitoring disease in humans, plants, or animals, fast and accurate screening is essential to mitigating risk, protecting supply chains, and saving lives.

3CR Bioscience’s PCR-based solutions, including PACE and PACE OneStep RT-PCR, provide a scalable, versatile, and cost-effective approach to pathogen detection. Backed by real-world success stories and an ongoing commitment to innovation, our technology is expanding what’s possible redefining the frontiers of molecular diagnostics in agriculture and life sciences.

If you’re looking to implement or improve your pathogen detection system, contact us to learn how PACE can work for you.

MORE POSTS

Automated Pipetting vs. Manual Pipetting: Which Is Right for Your Lab?
Discover when manual pipetting is enough—and why automated pipetting with 3CR’s GeneArrayer and PACE® genotyping delivers superior speed, accuracy, and scalability.
High-Throughput PCR in CRISPR Screening and Genome Editing Verification
Discover how high-throughput PCR using PACE® genotyping accelerates CRISPR screening and genome editing verification across large sample populations.
Understanding the genetics of important traits in hemp to help breed improved cultivars
Learn how Cornell University uses PACE® SNP genotyping to accelerate hemp breeding—enabling early trait selection, sex determination, and cost-effective genetic screening.

Our product portfolio for your PCR genotyping workflow

Our portfolio of products and services include PACE® genotyping chemistry, instruments, and lab services to streamline every step of your workflow. Designed for life sciences, biotech, and agricultural research, our high-performance reagents, reliable instruments, and expert lab support help you achieve accurate, consistent results while reducing time and costs – making science affordable.

[fibosearch]
This field is for validation purposes and should be left unchanged.
Name(Required)

Contact us

Stay up to date with all things 3CR. 

Sign up now to receive insights, updates 
and industry case studies. 

This field is for validation purposes and should be left unchanged.
Name(Required)

MEET OUR TEAM

Steve AsquithManaging Director
Steve began his career in the Genetics Division of GlaxoSmithKline, as part of the team establishing GSK’s high-throughput core genotyping laboratory. Steve joined KBioscience when it was first founded in 2002 and was a key driver in taking the company from a small start-up to a multi-national service laboratory, quickly growing the company’s revenue to over $7.5M p.a. Following the acquisition of Kbioscience by LGC in 2011, Steve was appointed Global Director of Operations for LGC Genomics, responsible for over 100 staff in Europe and N. America, successfully elevating the genotyping products and service business. Steve held a crucial leadership role until he left in 2016. In 2017 Steve joined forces with John Holme to create 3CR Bioscience, a new company with a mission to deliver outstanding, customer-focused genotyping products with innovation and affordability at its core.
Dr. John HolmeTechnical Director

John joined KBioscience shortly after it was founded, in 2003, and became Head of Technical Development, building the company’s genotyping and DNA extraction product portfolio and service delivery until 2011 when it was acquired by LGC. Post-acquisition, John was appointed Head of Technical Group for LGC Genomics, in charge of all Research & Development and Technical Support activities for the company. In this role John continued to build on the high-quality products and services provided to the companies growing customer base.

During the 19 years John has worked in commercial R&D, he has co-invented numerous highly successful products including PACE®, ProbeSure, KASP™, KlearKall, KlearGene, KlearAmp and KlearTaq™, creating breakthrough offerings in genotyping and extraction and generating huge revenues for the companies he has worked in. In 2017, he joined forces with Steve Asquith and started 3CR Bioscience. John is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Dr. Nisha JainOperations Director

Nisha has been innovating since the start of her career at Geneform Technologies developing Iso-thermal Genotyping Technologies. Nisha joined KBioscience in 2008, as Senior R&D Scientist and key account Technical Support Scientist, developing KASP and Klearkall performance and coinventing two further versions of KASP.

Nisha has more than 15 years’ experience working in molecular biology and genotyping technologies, with extensive experience in the areas of R&D, Quality Assurance and Customer Technical Support. She has technically assisted many giants of the industry with their protocol development and troubleshooting and continues to deliver high-quality support and guidance. In 2018, Nisha joined 3CR Bioscience as Operations Director where she continues to develop PACE and ProbeSure for an increasing range of applications, and to grow 3CR Bioscience’s new product pipeline. Nisha is dedicated to developing outstanding, innovative genotyping products and providing the very best technical support to customers globally.

Nazma SaffinGeneral Manager
For 20 years Nazma Saffin has worked and gained extensive expertise within the genotyping sector. Working at Kbioscience and then LGC, she has held operational leadership posts responsible for manufacturing and laboratory services. With experience of ISO 9001 implementation, production scale up and LEAN operations, Nazma has successfully led highly profitable production departments. Joining 3CR Bioscience in 2022, Nazma is committed to delivering operational excellence.
Greig PollandAutomation and Support Manager

Greig is a hands-on automation specialist and team leader with a strong background in laboratory and industrial automation. He has spent over 25 years developing, installing, and supporting automated systems that transformed laboratory workflows. During this time, Greig worked closely with scientists and engineers to tailor automation solutions for genotyping and molecular biology, an experience that sparked his lasting passion for combining technology with practical science.

Since then, Greig has built on that foundation through leadership roles where he leads automation and support operations. He’s known for being approachable, commercially minded, and deeply committed to helping teams and customers get the best from their technology.

Whether managing a complex automation rollout or helping a customer troubleshoot in real time, Greig brings a thoughtful, collaborative approach that keeps people ,not just machines, at the centre of what he does.